drugset / Trial / NCT03057535

Impact of NaHCO3- on Exercise Hyperpnea

NCT03057535

Phase 0 Completed 20 enrolled McGill University
RandomizedCrossoverTriple-blindTreatment

Summary

An abnormally high V̇E/V̇CO2 response to exercise is a key pathophysiological feature of patients with chronic cardiopulmonary disease that is associated with adverse health outcomes. It follows that any intervention capable of decreasing the V̇E/V̇CO2 response to exercise has the potential to improve clinical and/or patient-reported outcomes. The investigators of this trial will compare the effects of orally administered sodium chloride (4 g, placebo) and sodium bicarbonate (0.3 g/kg of body mass) on ventilation, breathing pattern, dynamic operating lung volume, gas exhange, cardiovascular, metabolic and symptom parameters during symptom-limited, high-intensity, constant-work-rate cycle exercise testing in healthy adults aged 20-40 years.

Timeline

Start
2015-05
Primary completion
2016-04
Completion
2016-09

Drugs

EvaluationDrugModalityDoseRoute
Subject sodium bicarbonate Diagnostic / imaging agent 0.3 g/kg Oral

Indications

No indication recorded.